These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 33612319)
1. [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?]. Lanthier L; Carignan A; Plourde MÉ; Cauchon M Rev Med Interne; 2021 Mar; 42(3):227-228. PubMed ID: 33612319 [No Abstract] [Full Text] [Related]
2. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results. Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A Front Immunol; 2021; 12():657711. PubMed ID: 33777055 [No Abstract] [Full Text] [Related]
3. Africa's need for more COVID-19 clinical trials. Makoni M Lancet; 2021 May; 397(10289):2037. PubMed ID: 34062137 [No Abstract] [Full Text] [Related]
4. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy. Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485 [No Abstract] [Full Text] [Related]
11. How to redesign COVID vaccines so they protect against variants. Callaway E; Ledford H Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888 [No Abstract] [Full Text] [Related]
12. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines. Joffe S JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069 [No Abstract] [Full Text] [Related]
13. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea. Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579 [TBL] [Abstract][Full Text] [Related]
14. Is there a role for childhood vaccination against COVID-19? Eberhardt CS; Siegrist CA Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210 [TBL] [Abstract][Full Text] [Related]
15. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control. Salvamani S; Tan HZ; Thang WJ; Ter HC; Wan MS; Gunasekaran B; Rhodes A Br J Biomed Sci; 2020 Oct; 77(4):168-184. PubMed ID: 32942955 [TBL] [Abstract][Full Text] [Related]
16. Novavax offers first evidence that COVID vaccines protect people against variants. Callaway E; Mallapaty S Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489 [No Abstract] [Full Text] [Related]
17. Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic. Baay M; Lina B; Fontanet A; Marchant A; Saville M; Sabot P; Vandeputte J; Neels P Biologicals; 2021 Jan; 69():76-82. PubMed ID: 33234420 [TBL] [Abstract][Full Text] [Related]
18. [Temporary suspension of AstraZeneca's vaccine; a reconstruction]. Maas DPMSM; Kramers C; Smit HJCA; Middeldorp S; Helsloot I Ned Tijdschr Geneeskd; 2021 Apr; 165():. PubMed ID: 33914428 [TBL] [Abstract][Full Text] [Related]
19. The UK has approved a COVID vaccine - here's what scientists now want to know. Ledford H; Cyranoski D; Van Noorden R Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887 [No Abstract] [Full Text] [Related]
20. COVID-19 vaccination and antirheumatic therapy. Arnold J; Winthrop K; Emery P Rheumatology (Oxford); 2021 Aug; 60(8):3496-3502. PubMed ID: 33710296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]